Agios Pharmaceuticals (NASDAQ:AGIO) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Agios Pharmaceuticals (AGIO) operate in?

Agios Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Agios Pharmaceuticals Stock (NASDAQ: AGIO) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 496.95K
Day Range	- - -
52 Wk Range	19.80 - 50.35
Market Cap	$2.59B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	5.18%
Days to Cover	7.81

Recent News

Agios Pharmaceuticals' Rare Blood Disorder Drug Misses Primary Goal In Pediatric Study, Stock Slides

Agios Pharmaceuticals' Phase 3 ACTIVATE-KidsT study results reveal that mitapivat achieved a 28.1% transfusion reduction in children with PK deficiency compared to 11.8% with placebo. Secondary endpoints show transfusion-free and normal hemoglobin responses in the mitapivat arm only.

Vandana Singh

Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio?

Mid-cap stocks saw significant gains last week, with top performers like AGIO, VRNT, and NVAX, causing analysts to raise their forecasts.

Lekha Gupta

Why Is Agios Pharmaceuticals Stock Trading Higher On Monday?

Agios Pharmaceuticals shares rose after it announced its Phase 3 ENERGIZE-T study of mitapivat in adults with transfusion-dependent alpha- or beta-thalassemia achieved the primary endpoint of transfusion reduction response.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Apr

May

Jun

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Agios Pharmaceuticals Inc

Sector

Health Care

Industry

Biotechnology

Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geare...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Agios Pharmaceuticals (AGIO) stock?

You can purchase shares of Agios Pharmaceuticals (NASDAQ:AGIO) through any online brokerage.

View our list of the best stock brokerages

Who are Agios Pharmaceuticals (AGIO) competitors?

Other companies in Agios Pharmaceuticals’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), SpringWorks Therapeutics (NASDAQ:SWTX), PTC Therapeutics (NASDAQ:PTCT) and Protagonist Therapeutics (NASDAQ:PTGX).

What is the forecast, or price target, for Agios Pharmaceuticals (AGIO) stock?

Agios Pharmaceuticals has a consensus price target of $52.00.

What is the current price for Agios Pharmaceuticals (AGIO)?

The stock price for Agios Pharmaceuticals (NASDAQ: AGIO) is $45.54 last updated September 18, 2024 at 4:00 PM EDT.

Does Agios Pharmaceuticals (AGIO) pay a dividend?

There are no upcoming dividends for Agios Pharmaceuticals.

When is Agios Pharmaceuticals (NASDAQ:AGIO) reporting earnings?

Agios Pharmaceuticals’s Q3 earnings are confirmed for Thursday, October 31, 2024.

Is Agios Pharmaceuticals (AGIO) going to split?

There is no upcoming split for Agios Pharmaceuticals.

What sector and industry does Agios Pharmaceuticals (AGIO) operate in?

Agios Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now